Hungary eyes 30% cut to pharma budget

Hungary's economic reform program, which will be announced next month, could include cuts of about 30 percent to the national drug reimbursement bill, the government has said. Report

Suggested Articles

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.

Gilead is hoping to score a patent extension on TAF meds, but patient advocates say that would reward conduct that harmed patients.